Image IQ: 73-year-old with History of Lung Mass Suffers Headaches

The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

SyMRI 3D reportedly combines precise estimates of regional brain volume with improved resolution bolstering accuracy with lesion analysis.

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

Emphasizing optimal balancing of patient safety and image quality, these authors discuss the impact of the specific absorption rate and B1+rms parameters upon radiofrequency exposure with MRI exams.

For people with COVID-19 related brain fog, emerging dynamic contrast-enhanced MRI (DCE-MRI) research findings revealed blood-brain barrier disruption in multiple brain regions, including temporal lobes and the frontal cortex, up to a year after active infection.